Patents by Inventor Rashid A. Fawwaz

Rashid A. Fawwaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of streptavidin to inhibit transplant rejection
    Publication number: 20040072728
    Abstract: This invention provides methods and articles of manufacture for inhibiting the immunological rejection of a transplant in a subject. The instant methods and articles are based on the use of streptavidin for inhibiting such rejection.
    Type: Application
    Filed: June 26, 2003
    Publication date: April 15, 2004
    Inventor: Rashid A. Fawwaz
  • Radionuclide labeled lymphocytes for therapeutic use
    Patent number: 4500508
    Abstract: Lymphocytes labelled with .beta.-emitting radionuclides are therapeutically useful, particularly for lymphoid ablation. They are prepared by incubation of the lymphocytes with the selected radionuclide-oxine complex.
    Type: Grant
    Filed: May 3, 1983
    Date of Patent: February 19, 1985
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Suresh C. Srivastava, Rashid A. Fawwaz, Powell Richards
  • Palladium-109 labeled anti-melanoma monoclonal antibodies
    Patent number: H819
    Abstract: Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.
    Type: Grant
    Filed: April 30, 1984
    Date of Patent: September 4, 1990
    Assignee: The United States of America as represented by the Secretary of Energy
    Inventors: Suresh C. Srivastava, Rashid A. Fawwaz, Soldano Ferrone